| 1 |
32998578 | Synthesis, molecular docking and ADMET prediction of novel swertiamarin analogues for the restoration of type-2 diabetes: an enzyme inhibition assay. | 2022 May |
1 |
| 2 |
33866313 | Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial. | 2022 |
3 |
| 3 |
34477540 | Impact of Sitagliptin on Non-diabetic Covid-19 Patients. | 2022 |
1 |
| 4 |
34779087 | A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. | 2022 Mar |
1 |
| 5 |
34952193 | Virtual screening and in vitro assays of novel hits as promising DPP-4 inhibitors. | 2022 Mar |
1 |
| 6 |
35086469 | DPP4 inhibitors: Could they be one of the solutions for COVID-19 patients with prediabetes? | 2022 Jan 27 |
1 |
| 7 |
35115253 | Metformin-based single pill drug combinations for type 2 diabetes in primary care England: A time trend analysis. | 2022 Apr |
1 |
| 8 |
35205190 | Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin. | 2022 Feb 17 |
2 |
| 9 |
35294449 | Stability of extemporaneously prepared sitagliptin phosphate solution. | 2022 |
2 |
| 10 |
35320256 | Sitagliptin: A promising DPP-4 inhibitor for prevention of acute graft versus host disease. | 2022 Mar |
1 |
| 11 |
35355800 | Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday. | 2022 |
2 |
| 12 |
35388920 | New enantioselective liquid chromatography method development and validation of dipeptidyl peptidase IV inhibitors using a macrocyclic glycopeptide (vancomycin) chiral stationary phase under polar ionic mode condition. | 2022 Jul |
3 |
| 13 |
35483674 | Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus. | 2022 Apr 28 |
1 |
| 14 |
35581701 | Efficacy and Safety of Sitagliptin in the Treatment of COVID-19. | 2022 May 17 |
1 |
| 15 |
35635037 | Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy. | 2022 May |
2 |
| 16 |
32741073 | Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: A systematic review and meta-analysis of randomized controlled trials. | 2021 Mar |
1 |
| 17 |
33098565 | Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study. | 2021 Jan |
1 |
| 18 |
33151168 | Sitagliptin: a potential drug for the treatment of COVID-19? | 2021 Jun 1 |
1 |
| 19 |
33205256 | [Alopecia areata universalis under treatment with sitagliptin : Possible immunological effect of dipeptidyl peptidase-4 inhibitors?] | 2021 Jul |
3 |
| 20 |
33214038 | Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors. | 2021 Jan 1 |
3 |
| 21 |
33387351 | DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway. | 2021 Aug |
1 |
| 22 |
33429063 | Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes. | 2021 Sep |
1 |
| 23 |
33615655 | The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities. | 2021 May |
3 |
| 24 |
33769204 | Anti-glycemic potential of benzophenone thio/semicarbazone derivatives: synthesis, enzyme inhibition and ligand docking studies. | 2021 Mar 26 |
1 |
| 25 |
33972682 | Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma. | 2021 Jun |
1 |
| 26 |
33975891 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study. | 2021 May |
2 |
| 27 |
34036983 | A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma. | 2021 Jun 24 |
3 |
| 28 |
34182806 | Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus. | 2021 May-Jun |
1 |
| 29 |
34384428 | Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors. | 2021 Aug 12 |
1 |
| 30 |
34388848 | Effects of Sitagliptin as Monotherapy and Add-On to Metformin on Weight Loss among Overweight and Obese Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. | 2021 Nov |
1 |
| 31 |
34484112 | Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China. | 2021 |
2 |
| 32 |
34635643 | Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury. | 2021 Oct 11 |
2 |
| 33 |
34926239 | DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells. | 2021 |
1 |
| 34 |
31468664 | Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes. | 2020 Jan |
1 |
| 35 |
31795778 | Formulation and optimization for DPP-4 inhibitor nanomicelles using response surface methodology. | 2020 Jan |
1 |
| 36 |
32133429 | Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin". | 2020 Mar 1 |
1 |
| 37 |
32133430 | Response to Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin". | 2020 Mar 1 |
1 |
| 38 |
32194335 | Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi Arabia. | 2020 Mar |
1 |
| 39 |
32301442 | Sitagliptin Inhibits Extracellular Matrix Accumulation and Proliferation in Lung Fibroblasts. | 2020 Apr 17 |
1 |
| 40 |
32317005 | Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus. | 2020 Apr 21 |
2 |
| 41 |
32362346 | An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men. | 2020 Jun |
1 |
| 42 |
32454763 | The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients. | 2020 Feb |
1 |
| 43 |
32534505 | Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. | 2020 May 17 |
1 |
| 44 |
32539832 | Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy. | 2020 Jun 15 |
1 |
| 45 |
32543789 | A Physiologically-Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP-1 and GIP and the DPP4 Inhibitor Sitagliptin. | 2020 Jun |
2 |
| 46 |
32559768 | Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 Jul |
1 |
| 47 |
32566677 | Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure. | 2020 |
1 |
| 48 |
32567544 | Acute effects of sitagliptin on progenitor cells and soluble mediators in newly diagnosed type 2 diabetes. | 2020 Sep |
1 |
| 49 |
32721805 | Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. | 2020 Oct |
2 |
| 50 |
32767343 | Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3. | 2020 Aug |
1 |